ClinicalTrials.govpublic full text
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
prostate cancer, adenocarcinoma of the prostate, stage iv prostate cancer, recurrent prostate cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994082
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.